FDA approves generic version of Vumerity for relapsing MS
by Patricia Inacio, PhD | November 18, 2025 Zydus capsules to be used for same indications as brand-name treatment Zydus Lifesciences received final approval…
Categories
Latest Blog Posts
- A Request from YOUR MS Peer, asking you to HELP us (MS Views and News) Make an Impact! 💙
- video: Optic Neuritis MRI Orbits Findings
- video: Remyelination in MS
- video: Curious about early MS symptoms doctors often miss?
- video: SMALL IMPROVEMENTS Matter
- video: Multiple Sclerosis Progression, Independent from relapse Activity
- Living with MS: Sometimes One Really Is the Loneliest Number
- MOGAD has unique immune signature distinct from MS: Study
- FDA approves generic version of Vumerity for relapsing MS
- New Biological Mechanism Boosts Myelin Production in the Brain
- 4 Vitamin B12 Deficiency Symptoms You Need to Know
- Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
- Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- UIC Study: Remote Pilates Program for People Living with MS
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
- Trigeminal neuralgia and MS
- What Is an MS Zinger and How Can You Manage It?
- What to know about itching and MS
- Two compounds with potential for myelin repair in MS identified
